An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension

AstraZeneca

Status: Completed

Conditions: Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT01201980

NIS-CRS-DUM-2010/2

Details and patient eligibility

About

This study is aimed to evaluate response rate of the antihypertensive treatment with a calcium antagonist in real life practice, to evaluate patients' quality of life and to collect the following Serbia-specific epidemiology data on hypertension: demographic data, patents characteristics, and patients' management/treatment.

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Subject population with essential arterial hypertension currently receiving treatment with a calcium antagonist

Trial design

300 participants in 1 patient group

1

Description:

Subject population with essential arterial hypertension currently receiving treatment with a calcium antagonist